Novel vaccine safe, effective in ovarian cancer subset
June 11, 2021 8:51 amA novel vaccine appeared safe and demonstrated clinical benefit as front-line maintenance therapy for women with advanced-stage ovarian cancer, according to results of a phase 2b trial presented during the virtual ASCO Annual Meeting.… Read more